{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-086081","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.958485+00:00","generated_at":"2026-05-31T12:18:52.838446+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rhythm Pharma Q2 2024 revenue $29.1M, up 52% YoY; net loss narrows to $33.6M","bullets":["Net product revenue $29.1M vs $19.2M in Q2 2023; 74% generated in United States.","Net loss attributable to common stockholders improved to ($33.6M) or ($0.55)/share from ($46.7M) ($0.82)/share.","Cash balance $319.1M as of June 30, 2024, up from $275.8M at Dec 31, 2023; runway into 2026.","Dosed first patients in Japanese cohort for hypothalamic obesity Phase 3 trial; top-line data from pivotal cohort expected 1H 2025.","Completed sNDA submission to FDA for IMCIVREE in children age 2-6; EC already expanded to age 2 in Europe."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-086081","json":"https://secwatch.observer/filing/0001104659-24-086081.json","markdown":"https://secwatch.observer/filing/0001104659-24-086081.md","text":"https://secwatch.observer/filing/0001104659-24-086081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924086081/0001104659-24-086081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924086081/tm2420827d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:18:52.838446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}